ASH 2022 Post Conference Perspectives: Emerging Treatments in Multiple Myeloma

home / post-conference-perspectives / ash-2022-post-conference-perspectives-emerging-treatments-in-multiple-myeloma

Saad Usmani, MD, MBA, FACP highlights abstracts in multiple myeloma from the ASH 2022 Annual Meeting and Exposition.

Episodes

AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo